The Evolving Global Landscape in Vaccine Development: Novotech and Endpoints News Webinar
SYDNEY, AU, Feb 15, 2023 […]
ป้ายกำกับ: clinical
Novotech Global Report: Robust Phase 1 Trial Growth Across Asia Pacific
SYDNEY, AU, Feb 10, 2023 […]
Novotech Acquires European CRO, Strengthens Global Operations
SINGAPORE, Jan 12, 2023 & […]
Novotech Acquires US-based Drug Development Consulting Firm, CBR International
SINGAPORE, Jan 12, 2023 & […]
Avance Clinical Celebrates GlobalReady Success as more than 40 Biotech Clients Enter Program
SAN FRANCISCO, CA, Jan 11 […]
China Biotech Services subsidiary AMDL nominated as Top Clinical Laboratory Services Company in APAC 2022 and receives CAP Accreditation Certificate
HONG KONG, Jan 10, 2023 & […]
HighTide Therapeutics Raises $107 Million in Series C/C+ Financing to Advance Innovative Pipeline and Business Collaborations
ROCKVILLE, MD and SHENZHE […]
Novotech Chairs BioCentury Summit Workshop on How to Build and Finance an East-West MRCT Strategy
SYDNEY, AU, Nov 11, 2022 […]
Led by Legend Capital, PureFDA Secures Over CNY100 million in the Series B Round
HONG KONG, Nov 10, 2022 & […]
Clinical Research Opportunities in China and the Path to USFDA Approval – Whitepaper
SYDNEY, AU, Oct 25, 2022 […]
The Biotech Landscape Webinar: Market Trends, Priorities, Predictions, and Pathways to FDA Approval
SYDNEY, AU, Oct 17, 2022 […]
Novotech Selected as Scrip Awards Finalist for Best Full-Service CRO
SYDNEY, AU, Oct 7, 2022 & […]
Avance Clinical Wins International Health Award for Biotech CRO Services
SYDNEY, AU, Sep 28, 2022 […]
Avance Clinical Announces North American CRO Acquisition to Expand Later Phase Services for Biotechs
SYDNEY, AU, Sep 6, 2022 & […]
Novotech at ESMO Congress 2022 – New Data Shows 100% Oncology Trials Growth in APAC
SYDNEY, Sep 5, 2022 ̵ […]
APAC Attracts 50% of Global Clinical Trials According to New GlobalData Report
SYDNEY, Sep 2, 2022 ̵ […]
Avance Clinical Sponsors Biotech Company of the Year Awards at Informa Pharma Intelligence Awards 2022
ADELAIDE, AUS, Aug 29, 20 […]
Legend Capital Portfolio: China-leading CRO Enterprise R&G Pharmastudies Listed on the ChiNext Market Successfully
HONG KONG, Aug 15, 2022 & […]
Novotech’s Flexible Work Policy is Finalist in Best Workplace Flexibility Program “Excellence Award 2022”
SYDNEY, Jul 25, 2022 R […]
Novotech Receives “Best Biologics CRO Award 2022” at Korea Bioprocessing Excellence Awards 2022
SEOUL, S.KOREA, Jun 29, 2 […]
Novotech Receives CRO Leadership Award for Exceeding Customer Expectations
CHICAGO, IL, Jun 23, 2022 […]
SinoMab Dosed First Healthy Subject in Phase I Clinical Trial of SM17 in the U.S.
HONG KONG, Jun 15, 2022 & […]
Novotech Sponsors Endpoints ASCO 2022 Expert Panel on Accelerating Oncology Clinical Trials in China
SYDNEY, Jun 6, 2022 ̵ […]
Novotech Sponsors Pre-ASCO China Summit: Go/No Go Decisions Based on Early Phase Oncology Trials
SYDNEY, May 12, 2022 R […]
